SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medi-Caps informs about newspaper advertisement

12 Nov 2021 Evaluate

Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(1)(a) of SEBI (LODR) Regulations, 2015 regarding extract of Standalone and Consolidated Un-Audited Financial Results for the quarter/ half year ended on 30th September, 2021 which was approved by the Board in their 05/2021-2022 Board Meeting held on Wednesday, 10th November, 2021 at the Corporate Office of the Company situated at 201, Pushpratna Paradise 9/5 New Palasiya, Opposite UCO Bank Indore (MP) 452001. Medi-Caps has informed it enclosed the newspaper advertisement published on 12th November, 2021 in ‘Free Press Journal English edition and Choutha Sansar Hindi edition'.

The above information is a part of company’s filings submitted to BSE.

Medi-Caps Share Price

29.85 -1.02 (-3.30%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×